San Diego-based Illumina, Inc. is a life science tools and integrated systems company that has been a key player in the analysis of genetic variation and function. Operating through its Core Illumina and GRAIL segments, the company offers sequencing and array-based instruments and consumables, such as reagents, flow cells, library preparation, whole-genome sequencing kits, and targeted resequencing kits. Illumina also provides genotyping and product support services, and in recent years, it has broken new ground with Galleri, its multi-cancer early detection test. The company caters to a diverse clientele comprising genomic research centers, academic institutions, government laboratories, hospitals, and biotechnology firms, among others. It markets and distributes its products primarily in North America, Europe, Latin America, and the Asia-Pacific region. Illumina, Inc. was founded in 1998 and has since been instrumental in empowering scientists and researchers around the world with its cutting-edge products and services.